PRL and COVID-19: This is a clear indication that the studied mRNA COVID-19 vaccine BNT162b2 has the potential to cause menstrual irregularities by inducing perturbations in the genes and/or proteins involved in prolactin signaling pathways (i.e., through affecting the activity of key transcription factors involved in this pathway).